As an enterprise deeply engaged in the field of medical and health AI, Shukun Technology has always adhered to originality and continuously accelerated innovation in the industry.
Following the first launch of the "Digital Human Body" version 1.0 at the CMEF conference in 2021, version 2.0 in 2023 will follow. Now, with the opportunity of the just-concluded CMEF event, Shukun Technology announced that it will upgrade the "Digital Human Body" platform to version 3.0, and the R&D cycle has been shortened to one year.
This speed is unexpected by many people, but it is also in line with the logic of industry development. After all, in the arena of the convergence of healthcare and AI, there is never room for slackness.
"The entire industry is going all out to pursue large models, software and hardware integration, and full life cycle management. Whether it's a top AI research institute or a leader in various industries, there are no exceptions. This is the general consensus among industry insiders.
In this competition, there are only a handful of companies that can fully and deeply grasp these three aspects. "Digital Human Body", as an industrial-level AI technology platform independently created by Shukun Technology, is now an important carrier that combines the three into one.
Correspondingly, these are the three highlights of the "Digital Human Body" 3.0 platform:
First, on the basis of version 2.0, it introduced advanced large model technology and launched "ShuKunGPT", realizing the leap from a dedicated small model to a general large model.
Second, version 2.0 realizes the comprehensive AI of medical equipment (such as CT, MRI, DR, ultrasound, etc.) through software, and version 3.0 further empowers the hardware with artificial intelligence capabilities, achieving an innovative breakthrough from software to software and hardware integration.
Third, compared with the original version 1.0, which only empowers the original AI technology in the field of medical imaging, Digital Human Body 3.0 has expanded the original AI capabilities to the field of medical and health care scenarios.
In the dialogue with Leifeng.com, Zheng Chao, CTO of Shukun Technology, summed it up in one sentence: "Medical imaging and AI will inevitably continue to be deeply combined, especially since this year, the 'new quality productivity' represented by AI has been written into the government work report, which is not only the east wind taken by the industry, but also a test to feed the industry." ”
Now, Shukun Technology has reached its seventh year of establishment, what has it done right, and where should it go next?
The change of underlying thinking brought about by the large model
"We have always adhered to the combination of medicine and engineering, and hope that every innovation can be transformed into a product, integrated into the daily workflow of doctors, and truly serve the majority of doctors and patients. This is the development concept that Shukun Technology has adhered to since the first day of its establishment.
This philosophy runs through every member of the company, from the founder, CTO to the grassroots staff, who are committed to closely meeting the needs of customers, that is, understanding the real pain points of doctors and patients, so as to promote the precise application of technology, product experience and iterative efficiency.
Zheng Chao, CTO of Shukun Technology, emphasized in a dialogue with Leifeng.com: "Technology landing and user experience are always hard work, both hard work and ingenuity, there is no ready-made answer to what users need, Shukun Technology is still in-depth clinical links, do their own observation and thinking." ”
Just as in the past year, AI technology represented by large models has gone to thousands of industries, and at the same time, Shukun Technology is also accelerating the exploration of the application potential of this technology in the medical field.
Zheng Chao believes that "Scaling Laws" are the key to insight into this phenomenon. "We have witnessed the continuous validation of the law of scale, which means that the development from a single model to a universal model, from a single modality to a full modality, will be an important cornerstone of the next generation of intelligent medical solutions," he said. ”
Specifically, Scaling Laws reveals that as the size of a model (including the number of model parameters, the size of the training data, and the computational resource input) increases, the performance will also increase, and it will follow a power-law relationship. In the medical scenario, this means that the application of AI is becoming more efficient and accurate, whether it is consultation, image-assisted diagnosis, surgical treatment, or health management.
Different from the doubts of enterprises and doctors about "AI + healthcare" in the past, "comprehensive AI in healthcare" has now become an urgent need of the industry. Along this line of thinking, ShuKun Technology has independently developed a large medical and health model - ShuKunGPT, and used it as the infrastructure of the "Digital Human Body" 3.0 platform.
In the list released by CMB, the world's largest Chinese medical evaluation list, Shukun Technology GPT ranked first. At the same time, Shukun Technology has also implemented the technology through scientific research cooperation and cooperation with health management departments.
CMB Chinese Large Model Evaluation List (Partial)
According to the scenario, ShuKunGPT provides two major functions: "Digital Doctor Assistant" and "Family Digital Doctor":
On the physician side, ShuKunGPT aims to improve doctors' work efficiency, assist in accurate diagnosis, and empower the whole clinical chain.
When patients come to primary hospitals for screening, Shukun digital doctors support the identification of lesions in all human organs, assist doctors to improve the efficiency of image reading and diagnosis, and automatically generate imaging diagnostic reports. Shukun's unique "1+X" intelligent screening function can realize one inspection, screen for multiple diseases, benefit the people with low dose and low cost, and empower the grassroots with high efficiency and strong medical technology.
When medium and high-risk patients come to tertiary hospitals for medical treatment due to difficult diseases, Shukun digital doctors can not only help doctors better grasp the patient's situation based on the screening content, but also help doctors record standardized medical records to assist in diagnosis and treatment from a personalized and multidisciplinary perspective. While improving the efficiency of diagnosis and treatment in tertiary hospitals, it also makes disease identification faster and more accurate.
On the patient side, ShuKunGPT provides patient-centered health management throughout the life cycle.
It provides a comprehensive understanding of the medical data of users and patients, and understands the needs of patients as deeply as doctors. Whether it is at home, in a community hospital, or in a complex disease diagnosis and treatment scenario, ShuKunGPT can provide a full range of personalized solutions.
Mao Xinsheng, founder and chairman of Shukun Technology, explained at the press conference: "Medical imaging is the cornerstone of clinical diagnosis, disease treatment and health management, and it is also the entry point for AI research and development of Shukun Technology. With the comprehensive layout and leading of medical imaging scenarios, Shukun Technology has realized the spillover of 'AI+' capabilities, and we can provide all-round and personalized solutions for complex disease treatment or health management at home and for the elderly. ”
Furthermore, this also hints at the transformation of Shukun Technology from "to B" to "to B+to C" two-wheel drive mode. Behind this, a series of combat technology deployments of Shukun Technology have taken shape.
Why does Shukun Technology value "AI-native intelligent manufacturing"?
At the press conference of "Digital Human Body" 3.0, in addition to the eye-catching large-scale model technology, "software and hardware integration" has also become a focus.
The intelligent ultrasound solution of Shukun defines a new generation of ultrasound workflow in the way of software and hardware integration. Shukun Technology integrates AI system and ultrasound equipment, and the world's first "Turing Brain" and "Turing Eagle Eye" hardware technology.
The "Turing Brain" has the ability of real-time and rapid detection and diagnosis, and the "Turing Eagle Eye" reality augmented technology overcomes the inconvenience of relying on the "second screen" to view the detection and diagnosis results, and can display the detailed information of the lesion on the original ultrasound screen in real time, further optimizing the disease detection and diagnosis process, and leading the development of the ultrasound AI industry. Smart ultrasound solutions have been applied to breast, thyroid, obstetrics and other fields, significantly improving the quality and efficiency of medical services.
In addition, based on the clinical needs of lung, hepatobiliary, urinary and other surgeries, Shukun Technology has launched a new smart surgical solution. It can realize panoramic map reconstruction of surgery, intelligent identification of vascular variation, innovative wedge resection method, navigation and positioning of puncture surgery, etc., and comprehensively cover surgical operations. The smart surgical solution breaks the barriers of traditional surgical experience and empowers the whole process of clinical surgery with original AI technology, so that young doctors can operate calmly, making surgery smarter, more accurate and safer.
As large-scale model technology continues to increase AI systems, the most important thing for today's medical and health AI companies is their own hardware capabilities.
"To go further, it is to build 'AI-native intelligent manufacturing' capabilities. Mao Xinsheng, founder and chairman of Shukun Technology, at the press conference of "Digital Human Body" 3.0, the integration of software and hardware is the key to AI's continuous breakthrough of technological boundaries, and it is also the reconstruction of user experience.
Mao Xinsheng, founder and chairman of Shukun Technology
Nowadays, with the whole process of independent research and development and production of surgical robots, intelligent ultrasound, etc., as a symbol, Shukun Technology has gradually transformed from a single software platform to achieve end-to-end deep integration of software and hardware.
From this point of view, "Digital Human Body" 3.0 is not only a concentrated demonstration of Shukun Technology's AI-native intelligent manufacturing capabilities, but also every step and every second of interaction between doctors and equipment will be blessed by AI. This is not only a leap forward in technology, but also a sign that AI will reshape every aspect of the medical physics world and open a second growth curve to improve quality and efficiency.
The next step for Shukun Technology
If we make an analogy, AI and intelligent manufacturing are tantamount to two legs, which have led Shukun Technology to a critical period of feeding back the industry.
It is reported that the scientific research achievements of Shukun Technology have been accepted by international top journals such as "Radiology", "Nature Communication" and "Science Bulletin", and the products have attracted attention and sought after at international events such as RSNA and ECR, and have established cooperative relations with medical institutions and research institutions in the United States, Europe, Japan, Southeast Asia, the Middle East and other countries and regions, all of which are effectively promoting the progress of the global medical AI industry.
In addition, Shukun Technology has participated in a number of national industry standard formulation projects, such as "Evaluation Standard for Artificial Intelligence Assisted Diagnosis System for Chest CT Pulmonary Nodules" and "Special Technical Conditions for Coronary CT Image Processing Software" to promote the standardization of medical AI.
This also means that for today's Shukun Technology, the top-level design has been completed, and the follow-up challenge is how to effectively implement these innovative technologies.
Zheng Chao, CTO of Shukun Technology, told Leifeng.com that the advantage of Shukun Technology is that its original technology has been greatly recognized by clinical practice, and its large-scale and industrialized application is comprehensively leading.
For example, Shukun Technology is the first company in the industry to launch the concept and product of "cardiopulmonary screening", which can complete the early warning of multiple early screening results such as lung diseases and coronary heart disease with only one low-dose chest spiral CT, filling the market gap of early screening of coronary heart disease risk in the health examination scenario.
At present, it can be upgraded to "one scan and multiple checks" according to the needs of specific scenarios, and realize comprehensive screening and intelligent assessment for many diseases such as pulmonary nodules, pneumonia, emphysema, chest fractures, bone destruction, bone density, and ungated calcification points.
Shukun Technology's one-stop stroke solution has played a great role in helping Xuanwu Hospital build a stroke greenway, minimizing the DNT time of patients.
According to a recent paper published in Science Bulletin, compared with semi-automatic CT-FFR, the one-stop automatic CT-FFR technology of Shukun Technology has shortened the operation time by 3 times, and the full processing can be completed in less than 4 minutes, and the number of mouse clicks of doctors has also been shortened from an average of 60 times to 1 time.
In addition to the original and leading technology, Shukun Technology has covered nearly 4,000 medical and health institutions around the world, has unique advantages in large-scale and industrial application, and has created a new hierarchical diagnosis and treatment service model of AI+ medical health in the region, which has been successfully implemented in Changping, Beijing, and Wuzhong, Suzhou, to improve the quality and efficiency of primary medical services in an all-round way.
In addition, Zheng Chao said that Shukun Technology will continue to explore the possibility of internationalizing the market. At present, Shukun Technology has obtained FDA and CE certification, and has carried out registration and scientific research cooperation in Singapore, Egypt, the United States and other places, contributing to the development of global medical and health undertakings.
With the continuous progress and innovation of Shukun Technology, we have reason to believe that it will continue to lead the development of medical AI technology on a global scale, bringing more hope and opportunities for the future of the medical industry.